Yanguang Cao

33PUBLICATIONS
49CO-AUTHORS
Haematological tumoursPharmacogenomicsClinical pharmacology and therapeuticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 07, 2026
Causal Inference Approaches to Estimating the Effect of Ibrutinib Dose Modifications on Progression-Free Survival in Chronic Lymphocytic Leukemia.

|May 15, 2026
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma.

|Apr 14, 2026
When Selectivity Increases Uncertainty: Context-Dependent Pharmacology in Antibody Drug Development.

Xiaozhi Liao, Yanguang Cao

|Mar 13, 2026
Quantitative Lesion-Level Modeling Reveals Organ-Dependent Therapeutic Response.

Ian Dilley, Jiawei Zhou, Quefeng Li

|Feb 16, 2026
Prognostic Model-Guided Randomization Improves Efficiency in Early-Phase Trials: Evidence From Surveys and Simulations.

Sihong Zhang, Justin Zhao, Yanguang Cao

|Nov 26, 2025
Endpoint Exposure-Response Analyses in the Presence of Concurrent Dose Modification During Clinical Trials.

Rui Zhong, Yanguang Cao

Pageof 6

Frequent Collaborators

4 joint publications

Timothy Qi

3 joint publications

Rui Zhong

3 joint publications

Xiaozhi Liao

2 joint publications

Ian Dilley